Other namesTypes of Charcot-Marie-Tooth neuropathy type 2XCauses and contributing factorsSymptoms and signsDiagnostic testsNon-pharmacological treatments (therapies and others)Drug treatmentsDietary molecular supplementsRegenerative, immune-boosting and stem-cell-related drugsSurgical optionsPrevention and lifestyle measuresWhen to see doctorsWhat to eat and what to avoidFrequently asked questions (FAQs)Charcot-Marie-Tooth neuropathy type 2X (often grouped under X-linked Charcot-Marie-Tooth disease, or CMTX) is a rare inherited nerve disease that mainly affects the peripheral nerves in the legs, feet, arms, and hands. These nerves slowly lose their ability to carry signals, so muscles become weak and thin and sensation (feeling) in the feet and hands is reduced. In most families this condition is caused by a change (mutation) in the GJB1 gene, which makes a protein called connexin-32 that helps nerve-supporting cells (Schwann cells and some brain cells) communicate with each other.NCBI+1Charcot-Marie-Tooth neuropathy type 2X (often grouped within X-linked CMT or CMTX) is a rare inherited nerve disease that mainly affects the long nerves in the arms and legs. It is usually caused by harmful changes (mutations) in a gene called GJB1, which produces a protein called connexin 32. This protein helps nerve cells talk to each other. When the gene does not work properly, the covering and inside of the peripheral nerves slowly become damaged. Over time, this can cause foot weakness, foot deformity (such as high-arched feet), problems with balance, reduced sensation, and sometimes mild problems in the brain or spinal cord as well. There is no medicine that can cure or stop CMT2X yet, so treatment focuses on protecting function, reducing pain, and preventing complications through a team approach involving neurologists, physiotherapists, orthotists, and other specialists. NCBI+2In this disease, symptoms usually begin in childhood, teenage years, or early adult life and worsen slowly over many years. People often notice trouble running, frequent ankle sprains, high-arched feet, or difficulty with fine hand tasks such as buttoning or writing. Both males and females can be affected, but males usually have more severe problems because they have only one X chromosome.NCBI+1Some people with GJB1-related disease also have central nervous system (CNS) features, such as brief “stroke-like” episodes with weakness or speech problems, or white-matter changes seen on brain MRI. These episodes usually improve, but they show that this condition can affect both the peripheral nerves and the brain.NCBI+2Lippincott Journals+2Other namesDoctors and researchers use several names for Charcot-Marie-Tooth neuropathy type 2X. All of these refer to very closely related or overlapping conditions:X-linked Charcot-Marie-Tooth disease (CMTX) – the most common broad name.NCBI+1GJB1-related Charcot-Marie-Tooth neuropathy – highlights the gene involved (GJB1).NCBI+1Charcot-Marie-Tooth neuropathy type 1X (CMT1X) – traditional name; many GJB1 cases were first classified here because they show intermediate or demyelinating nerve conduction findings.Frontiers+1Charcot-Marie-Tooth disease type X (CMTX) or Charcot-Marie-Tooth disease, X-linked dominant, 1 – names used in genetic and disease databases.MalaCards+1X-linked hereditary motor and sensory neuropathy (X-linked HMSN) – older term meaning the same family of disorders.NCBI+1Because the exact pattern of nerve damage (more axonal or more demyelinating) can differ between families, you may see slightly different subtype labels (for example, “intermediate CMTX” or “CMT2-like X-linked neuropathy”) in specialist papers, but they all point back to GJB1-related X-linked CMT.Frontiers+1Types of Charcot-Marie-Tooth neuropathy type 2XExperts often describe “types” of CMT2X/CMTX based on how the disease behaves, not because there are completely different diseases. These clinical patterns can overlap in the same family:NCBI+1Classic peripheral neuropathy type – the most common pattern, with slowly progressive weakness and wasting in the feet and lower legs, later in the hands, together with numbness and reduced reflexes.Frontiers+1Peripheral neuropathy with CNS involvement – in some people, the peripheral neuropathy is joined by episodes of slurred speech, sudden weakness, or changes on brain MRI that look like white-matter disease but often improve over time.Lippincott Journals+1Intermediate conduction type – nerve conduction studies show velocities between typical demyelinating (slow) and typical axonal (normal speed but low amplitude) values, so this pattern is called “intermediate CMTX.”Frontiers+1Mild or late-onset type – some people, especially females, have very mild symptoms such as slightly weak ankles or mild sensory loss and may be diagnosed only after another family member is tested.NCBI+1Early-severe type – in a minority of families, boys may show early walking problems, more marked disability, or more frequent CNS events, often related to particular GJB1 mutations.Perelman School of Medicine+1These “types” are useful clinically, but genetically they all share GJB1 mutations on the X chromosome, so they are considered expressions of the same core disorder.NCBI+1Causes and contributing factorsThe main true cause of Charcot-Marie-Tooth neuropathy type 2X is a harmful change in one copy of the GJB1 gene. The GJB1 gene provides instructions to make connexin-32, a gap-junction protein used in myelin-forming cells. When the gene is faulty, the protein does not work correctly, and the myelin and axons of peripheral nerves gradually fail.NCBI+1Below are 20 causes and contributing factors that explain why this disease appears and how it can vary between people:Missense mutations in GJB1 – a single “letter” change in DNA swaps one amino acid in connexin-32 for another. Many different missense mutations have been linked to CMTX.Perelman School of Medicine+1Nonsense mutations – these changes create a premature “stop” signal, so a shortened, non-functional connexin-32 protein is produced or destroyed by quality-control systems.Perelman School of Medicine+1Frameshift mutations – small insertions or deletions in the gene shift the reading frame, severely disturbing the structure of connexin-32 and leading to loss of function.Perelman School of Medicine+1Splice-site mutations – changes near the edges of exons can cause abnormal RNA splicing, so important parts of the protein are skipped or mis-joined.Perelman School of Medicine+1Non-coding (promoter or 5′UTR) mutations – some families have disease-causing changes in the regulatory region of GJB1 that reduce how much connexin-32 is made, even though the coding sequence is intact.Perelman School of Medicine+1Large deletions or duplications in GJB1 – rare structural changes that remove or duplicate big parts of the gene can also lead to loss of normal protein function.Perelman School of Medicine+1X-linked inheritance from a carrier or affected mother – sons who inherit the X chromosome with a GJB1 mutation almost always develop the disease; daughters who inherit it may be mildly or moderately affected.NCBI+1X-linked inheritance from an affected father – an affected man passes his X chromosome to all of his daughters (who may become carriers or have mild disease) but not to his sons (who receive his Y).Orpha+1De novo (new) GJB1 mutations – sometimes the mutation appears for the first time in a child because of a random change in the egg or sperm; there may be no previous family history.NCBI+1Skewed X-inactivation in females – females have two X chromosomes, and in each cell one is turned off. If the healthy X is turned off in more Schwann cells, a female carrier can show stronger disease.NCBI+1Loss of normal gap-junction channels in Schwann cells – connexin-32 forms channels between layers of myelin. When these are missing or abnormal, nutrients and signals cannot move properly, leading to axonal damage.Perelman School of Medicine+1Toxic gain-of-function effects – some mutant connexin-32 proteins misfold, get stuck in the cell, or form abnormal channels, which may poison Schwann cells and worsen neuropathy.Perelman School of Medicine+1Involvement of oligodendrocytes in the CNS – connexin-32 is also expressed in certain brain myelin cells, so its loss can contribute to central white-matter involvement and transient CNS symptoms.NCBI+1Genetic modifiers in other myelin or axonal genes – variants in genes such as PMP22, MPZ or others may slightly change disease severity, although they are not the main cause.Perelman School of Medicine+1Family founder effects – in some populations, a single ancestral GJB1 mutation has spread through many related families, increasing disease frequency in that group.Nature+1Age-related axonal loss – even healthy people lose some nerve fibers with age; in CMTX, this natural loss adds to the inherited weakness of nerves, so disability often increases in later adult life.NCBI+1Mechanical stress on already fragile nerves – repeated ankle sprains, foot deformity, or pressure on nerves can reveal or worsen weakness in vulnerable axons, although they do not cause the mutation itself.Rare Awareness Rare Education Portal+1Metabolic or nutritional stress – conditions like diabetes, severe vitamin deficiencies, or toxic exposures can further damage peripheral nerves and make hereditary neuropathy more symptomatic.MalaCards+1Intercurrent infections or fever – in some people, CNS episodes or worsening of weakness happen around times of infection or metabolic stress, probably because the injured nervous system has less reserve.Lippincott Journals+1Incomplete understanding of all molecular pathways – research continues to uncover how different GJB1 mutations disturb cell signaling, calcium balance, and other pathways in myelin-forming cells, explaining why the same gene can give different clinical pictures.MDPI+1Symptoms and signsSlowly progressive weakness in the feet and lower legs – people often notice tripping, difficulty running, or “foot drop,” where the toes drag on the ground and the foot slaps when walking.Frontiers+1Muscle wasting (atrophy) of the calves and ankles – over time the muscles below the knees become thinner, giving a “stork-leg” appearance in some individuals.RCASTorage+1High-arched feet (pes cavus) and hammertoes – abnormal foot shape develops as some muscles become weak and others stay relatively strong, pulling the foot into a high arch with bent toes.Frontiers+1Frequent ankle sprains and unstable ankles – weak muscles around the ankle and altered foot structure make the ankle more likely to twist, especially on uneven ground.Charcot-Marie-Tooth Association+1Weakness in hands and intrinsic hand muscles – fine hand muscles can become weak, leading to difficulty with buttons, writing, zips, or opening jars.Frontiers+1Reduced or absent reflexes, especially at the ankles – when the doctor tests tendon reflexes with a hammer, they may be weak or missing because of nerve damage.NCBI+1Loss of vibration and position sense – people may not feel tuning-fork vibration or know exactly where their toes are without looking, making balance harder in the dark.NCBI+1Numbness or tingling in feet and hands – sensory nerves are affected, so people often describe “pins and needles,” burning, or numbness in a stocking-and-glove pattern.Charcot-Marie-Tooth Association+1Unsteady gait and balance problems – because of weakness and sensory loss, walking on uneven surfaces or in the dark feels unsafe, and some people sway when they stand still.RCASTorage+1Muscle cramps and fatigue – tired or overused muscles can cramp or ache, and overall fatigue is common after long activity because the remaining motor units work harder.Charcot-Marie-Tooth Association+1Neuropathic pain in some individuals – a minority have burning, stabbing, or electric-like pain due to irritated or damaged sensory fibers.MalaCards+1Cold, discolored, or slightly swollen feet – poor nerve control of blood vessels can make the feet feel unusually cold or look slightly bluish.Rare Awareness Rare Education Portal+1Tremor or shakiness – some people with GJB1 mutations have action tremor (shaking when they move), which may relate to both peripheral and central nervous system involvement.ScienceDirect+1CNS events such as transient weakness or slurred speech – a small number of patients experience temporary “stroke-like” episodes that improve, often associated with white-matter changes on MRI.Lippincott Journals+1Significant variability between family members – even with the same mutation, one person may have only mild foot deformity, while another may need walking aids in later life.NCBI+1Diagnostic testsDiagnosing Charcot-Marie-Tooth neuropathy type 2X involves combining clinical examination, electrodiagnostic studies, and genetic testing, with imaging or other tests when needed. Doctors first think about CMT when they see a slowly progressive, length-dependent neuropathy starting in childhood or early adulthood, with a family history that suggests X-linked inheritance.NCBI+1Physical examination testsFull neurological examination – the doctor checks muscle strength, tone, reflexes, sensation, coordination, and cranial nerves. In CMT2X, the typical pattern is distal weakness, distal sensory loss, and reduced ankle reflexes with preserved cognition and normal upper motor neuron signs between attacks.NCBI+1Gait assessment – the way a person walks can show foot drop, high-stepping gait, poor heel walking, or difficulty walking on toes and heels. The doctor may ask the person to walk in a straight line, on tiptoes, and on heels to reveal subtle weakness.Frontiers+1Foot and hand inspection – visual examination looks for pes cavus, hammertoes, calluses, ankle instability, high-arched or narrow feet, wasting of small hand muscles, and deformities such as clawing of toes or fingers. These changes support a long-standing neuropathy diagnosis.RCASTorage+1Reflex testing – using a reflex hammer, the doctor checks ankle, knee, biceps, and other tendon reflexes. In CMTX, ankle reflexes are usually absent early, while other reflexes may be reduced later in disease.NCBI+1Balance tests (Romberg and tandem stance) – standing with feet together and then with eyes closed tests how well vision, sensation, and inner ear systems work together. Wobbling or falling, especially with eyes closed, suggests sensory ataxia from peripheral neuropathy.NCBI+1Manual and functional testsManual muscle testing (MMT) – the examiner asks the person to push or pull against resistance at the ankle, knee, wrist, and fingers. Grading strength from 0 to 5 helps track progression and compare sides. Distal muscles (for example ankle dorsiflexors) are usually weaker than proximal muscles.RCASTorage+1Timed 10-meter walk test – the person is asked to walk 10 meters at a comfortable speed while the time is recorded. This simple test provides an objective measure of walking ability for follow-up visits and clinical trials.MalaCards+1Six-minute walk test – this measures how far a person can walk in six minutes on a flat surface. It reflects endurance, balance, and muscle strength and is often used as an outcome measure in neuromuscular research.MalaCards+1Hand function tests (pegboard or buttoning tasks) – fine motor tests involve placing small pegs in holes, picking up coins, or buttoning a shirt. Slowness or clumsiness indicates weakness and sensory loss in the hands.Frontiers+1Joint range-of-motion assessment – the clinician gently moves ankles, knees, wrists, and fingers to see if contractures or stiffness are present. Limited motion, especially in the ankles, often follows long-standing muscle imbalance and helps guide physiotherapy and orthotic planning.Charcot-Marie-Tooth Association+1Laboratory and pathological testsTargeted genetic testing of the GJB1 gene – once CMTX is suspected, DNA testing from a blood sample is used to look for mutations in GJB1. Finding a pathogenic variant confirms the diagnosis and allows accurate counseling for the family.NCBI+1Next-generation sequencing neuropathy panels – when the exact type of CMT is unclear, a gene panel including GJB1 and many other neuropathy genes can be ordered. This approach is efficient when several CMT genes are possible.NCBI+1Whole-exome or whole-genome sequencing – in complex or unsolved cases, broader sequencing can identify rare, novel, or non-coding GJB1 variants or reveal other neuropathy-related genes that may modify the phenotype.Nature+1Routine blood tests to exclude acquired neuropathies – tests such as blood glucose/HbA1c, vitamin B12, thyroid function, kidney and liver tests are not specific for CMT2X but help rule out diabetes, vitamin deficiency, or systemic illness that could mimic or worsen neuropathy.NCBI+1Nerve biopsy (rarely needed now) – a small piece of peripheral nerve, usually from the lower leg, may be examined under a microscope. In X-linked CMT, biopsy can show abnormal myelin and axonal loss, but because genetic tests are now widely available, biopsy is reserved for unclear cases.Perelman School of Medicine+1Electrodiagnostic testsNerve conduction studies (NCS) – this key test uses small electrical pulses to measure how fast and how strongly nerves carry signals. In many CMTX cases, motor conduction velocities are in an intermediate range (not as slow as typical demyelinating CMT1, not fully normal as pure axonal CMT2), and response amplitudes may be reduced, showing axonal loss.Frontiers+1Electromyography (EMG) – a very fine needle electrode is inserted into muscles to record electrical activity. EMG in CMT2X usually shows signs of chronic denervation and reinnervation (for example large motor unit potentials), confirming a longstanding motor neuropathy rather than a primary muscle disease.Frontiers+1Evoked potentials (for example, brainstem auditory or somatosensory) – in people with suspected CNS involvement, evoked potential tests can show slowed central conduction, demonstrating that the central myelinated pathways are also affected by the GJB1 mutation.Frontiers+1Imaging testsMRI of the brain – in some patients with GJB1 mutations, brain MRI shows reversible or persistent white-matter signal changes, especially during or after transient neurological episodes. These changes help distinguish CMTX-related CNS involvement from other causes such as stroke or multiple sclerosis.Lippincott Journals+1MRI of peripheral nerves or muscle MRI – high-resolution MRI can show thinning of distal muscles and sometimes enlarged or signal-changed nerves in hereditary neuropathies. While not specific, these findings support the diagnosis and help document disease burden over time.Radiopaedia+1Ultrasound of peripheral nerves – nerve ultrasound can visualize nerve size and structure at the bedside. In hereditary neuropathies, nerves may be mildly enlarged or show a characteristic pattern, offering a non-invasive tool that complements NCS and genetic testing.Radiopaedia+1Non-pharmacological treatments (therapies and others)Below are key non-drug treatments that are often used together. Evidence mainly comes from studies in people with different types of CMT, not only CMT2X, but the principles are similar.1. Individualized physical therapy exercise programA regular, gentle exercise program guided by a physiotherapist is one of the most important treatments for CMT2X. It often includes stretching, strengthening, balance, and light aerobic exercises such as walking or cycling. The main purpose is to keep muscles as strong and flexible as possible, slow contractures, and maintain walking ability for longer. Studies in CMT show that strength and endurance training can improve walking, daily activities, and quality of life when done safely and regularly, without over-fatiguing weak muscles. PMC+2PubMed+22. Stretching and contracture preventionDaily stretching of calf muscles, hamstrings, fingers, and toes can help prevent or delay fixed joint stiffness and deformity, which are common in CMT because weak muscles cannot fully balance stronger ones. The purpose is to keep joints moving through their full range and reduce pain from tight muscles. Stretching can be done actively or with night splints and is often recommended early in life in people with CMT, especially for the feet and ankles where high-arched (pes cavus) deformity is common. Pod NMD+2The Foundation for Peripheral Neuropathy+23. Balance and gait trainingMany people with CMT2X have foot drop, ankle instability, and poor balance, which increase the risk of falls. Physiotherapists use targeted balance tasks, gait re-education, and sometimes treadmill or virtual-reality training to help the brain and body relearn safer walking patterns. The purpose is to decrease falls, improve confidence when moving, and allow safer participation in school, work, and sports. Reviews show that targeted physical therapy can improve gait and balance in CMT, although protocols vary. MDPI+2Lippincott Journals+24. Ankle-foot orthoses (AFOs) and other bracesLightweight braces such as AFOs or in-shoe orthoses can support weak ankle muscles, correct or accommodate high arches, and reduce tripping. In children and adults with CMT, AFOs are often used for foot drop and pes cavus, while shoe inserts help with pain and mild balance problems. The aim is to stabilize the foot and ankle, improve walking, and decrease fatigue. Evidence suggests that orthoses can improve foot function and reduce pain, especially when carefully chosen and adjusted by orthotists or podiatrists who know CMT. Pod NMD+2The Foundation for Peripheral Neuropathy+25. Occupational therapy for hand and daily activitiesOccupational therapists help with hand weakness, clumsiness, and fatigue during daily tasks like writing, using a phone, typing, or dressing. They may teach joint protection strategies, provide adaptive tools (such as built-up pens or button hooks), and train energy-saving methods. The purpose is to keep independence at school, home, and work and to prevent overuse injuries of small hand muscles that are already weak from neuropathy. Charcot-Marie-Tooth Association+2Physiopedia+26. Assistive devices (cane, crutches, walker)If balance or leg weakness is more severe, simple devices like a cane, forearm crutches, or a walker may be used, especially outdoors or on uneven ground. The goal is to reduce falls and conserve energy, not to make the person “more disabled.” In CMT, using the right device at the right time is associated with less injury and better participation in daily life, especially during fatigue or illness. MDPI+2Taylor & Francis Online+27. Foot care and skin protectionBecause sensation in the feet is often reduced in CMT2X, people may not feel blisters, pressure spots, or small cuts. Regular foot checks, proper nail care, and comfortable shoes with enough room help prevent ulcers and infections. Many guidelines for CMT management stress yearly review by a podiatrist or foot-care specialist and daily self-inspection when possible. NCBI+2The Foundation for Peripheral Neuropathy+28. Pain management education and pacingEven before medicines are used, teaching about pacing activities, using heat or cold packs safely, relaxation, and gentle stretching can reduce chronic pain flares. The purpose is to give the person a sense of control over neuropathic and musculoskeletal pain. Multidisciplinary CMT care pathways often include non-drug pain strategies alongside medication, to minimise medicine doses and side effects. ScienceDirect+2MDPI+29. Psychological support and peer support groupsLiving with a chronic hereditary disease can cause sadness, anxiety, or frustration. Psychological counseling, cognitive-behavioural therapy (CBT), and peer support groups run by CMT organizations help people cope, plan for the future, and feel less alone. Studies in CMT and other neuromuscular disorders show that mental health support improves quality of life and helps people stick to exercise and rehabilitation programs. ScienceDirect+2Archives PMR+210. Genetic counseling for family planningBecause CMT2X is X-linked, the chance of passing the condition to children depends on whether the affected person is male or female. Genetic counselors explain inheritance patterns, testing options for relatives, and choices for future pregnancies. This does not change the condition itself but helps families make informed decisions and reduces anxiety. GeneReviews recommends genetic counseling as a standard part of care in GJB1-related CMT. NCBI+2BCBSM+211. Lifestyle and physical activity coachingPeople with CMT often have lower daily physical activity, which can increase the risk of obesity, diabetes, and heart disease. Coaches and physiotherapists can build gentle activity plans with realistic goals. The purpose is to keep the whole body healthy, not only the nerves, and to prevent other diseases that could worsen walking. Research shows that safe physical activity is usually beneficial and not harmful in CMT when carefully supervised. Taylor & Francis Online+2Archives PMR+212. Home safety and fall-prevention modificationsSimple changes at home—removing loose rugs, improving lighting, using grab bars in the bathroom, and keeping frequently used items within easy reach—can greatly lower fall risk. For someone with CMT2X, this can mean fewer injuries and hospital visits. Fall-prevention programs are widely recommended in neuromuscular and neuropathy guidelines because falls are a major cause of fractures and loss of independence. MDPI+2MDPI+2Drug treatmentsVery important: there is currently no FDA-approved drug that specifically slows or stops CMT2X itself. Medicines are used to treat symptoms such as neuropathic pain, muscle cramps, mood problems, and sleep issues. All doses below are general adult examples from FDA labels, not personal advice. Your neurologist will decide whether any of these are right for you, and they will use different dosing in children or teens.1. Gabapentin (Neurontin and similar)Gabapentin is a medicine originally developed for seizures but widely used for neuropathic pain, such as nerve pain after shingles. FDA labels for gabapentin describe effective adult doses between about 900 and 3600 mg per day in divided doses for postherpetic neuralgia. It works by binding to calcium channels in nerve cells and reducing abnormal firing, which may lessen burning or shooting pain. Common side effects include sleepiness, dizziness, and swelling in the legs. FDA Access Data+2FDA Access Data+22. Pregabalin (Lyrica, Lyrica CR)Pregabalin is a related drug that also targets calcium channels and is approved by the FDA for several neuropathic pain conditions, including diabetic peripheral neuropathy and postherpetic neuralgia. Typical adult starting doses are around 150 mg per day, divided, and can be increased based on effect and kidney function. It can help reduce nerve pain and improve sleep, but may cause dizziness, weight gain, and swelling. It must be used carefully in people with balance problems. FDA Access Data+2FDA Access Data+23. Duloxetine (Cymbalta, Drizalma Sprinkle)Duloxetine is an antidepressant that also treats neuropathic pain, including diabetic peripheral neuropathic pain. It increases serotonin and norepinephrine levels in the nervous system, which can reduce pain signalling. Adult doses for neuropathic pain are usually around 60 mg per day. Side effects can include nausea, tiredness, sweating, and dry mouth. It must be monitored for mood changes, especially in younger people. FDA Access Data+4FDA Access Data+4FDA Access Data+44. Tricyclic antidepressants (for example amitriptyline, nortriptyline)Tricyclic antidepressants are older antidepressant drugs that are often used in low doses at night to treat chronic nerve pain. They work by increasing certain neurotransmitters and blocking pain pathways in the spinal cord. Evidence from neuropathic pain research—not specific to CMT2X—shows they can help some people but may cause dry mouth, constipation, weight gain, and heart rhythm changes. Because of side effects and overdose risk, they must be prescribed and monitored carefully, especially in teens. MDPI+2ScienceDirect+25. Serotonin-norepinephrine reuptake inhibitors (for example venlafaxine)Aside from duloxetine, other SNRIs like venlafaxine are sometimes used off-label for neuropathic pain. They enhance serotonin and norepinephrine in the central nervous system and can help in mixed pain and mood problems. Evidence mainly comes from studies in diabetic neuropathy and other chronic pain conditions. Side effects are similar to other antidepressants, including nausea, blood pressure changes, and sleep problems. MDPI+2FDA Access Data+26. Topical lidocaine patchesLidocaine 5% patches provide local numbing of painful skin areas without strong effects on the whole body. They are approved for postherpetic neuralgia but are sometimes used off-label for small, well-defined painful areas in peripheral neuropathy. The patch is put on the skin for several hours and then removed. Side effects are usually mild skin irritation, but they must not be applied to broken skin. ScienceDirect+2MDPI+27. Topical capsaicin (cream or high-dose patch)Capsaicin, the active ingredient in chili peppers, can desensitize pain fibres in the skin when used regularly. High-dose patches are approved for neuropathic pain, and lower-dose creams are available over the counter in some countries. In studies, capsaicin can reduce pain but often causes burning or stinging at the start, so it must be used as instructed. It may be an option for localised foot pain in CMT2X, under supervision. ScienceDirect+2MDPI+28. Simple pain relievers (paracetamol/acetaminophen, NSAIDs)Many people with CMT2X also have musculoskeletal pain from joint stress, poor posture, or surgery. Simple medicines like acetaminophen or non-steroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen) can help short-term. They do not treat nerve damage itself but reduce inflammation and mechanical pain. NSAIDs must be used carefully in people with kidney, stomach, or heart disease, and dosing for teens should always be checked with a doctor. ScienceDirect+2MDPI+29. Muscle relaxants (for leg cramps and spasticity)In some people with CMT, muscle cramps or spasticity can be troublesome. Medicines such as baclofen or tizanidine are sometimes used to relax muscles and improve comfort. Evidence is mostly from other neurological conditions like spinal cord injury and multiple sclerosis, but the same principles may help in CMT-related cramps. Side effects include sleepiness and weakness, so doses must be increased slowly and monitored. MDPI+2ScienceDirect+210. Medicines for mood and sleep problemsChronic pain, fatigue, and disability can cause depression, anxiety, or insomnia. Modern antidepressants or sleep medicines can be part of treatment when psychological support alone is not enough. They do not treat the nerve disease but can strongly improve overall functioning and pain coping. Choice of drug must be individualized and carefully supervised in young people. Archives PMR+3FDA Access Data+3FDA Access Data+3Dietary molecular supplementsThere is no supplement proven to cure or reverse CMT2X, and evidence is usually from diabetic neuropathy or other nerve injuries. Supplements may sometimes be added as adjuncts to medical care after a doctor checks interactions and doses.1. Alpha-lipoic acid (ALA)ALA is a powerful antioxidant that can reduce oxidative stress and inflammation in nerves. Trials in diabetic peripheral neuropathy have shown that oral doses (often around 600 mg per day in adults) can improve pain, burning, and nerve conduction in some patients. The proposed mechanism is protection of mitochondria and the myelin sheath. Side effects may include nausea or stomach upset, and high doses have not been fully studied long-term. ClinicalTrials.gov+4PMC+4MDPI+42. Coenzyme Q10 (CoQ10)CoQ10 is involved in energy production in mitochondria and has antioxidant effects. Animal studies and some human studies in peripheral neuropathy show that CoQ10 can support nerve regeneration and reduce nerve damage related to oxidative stress. Typical study doses range from a few hundred to about 1200 mg per day in adults, but the best dose for inherited neuropathy is not known. It is usually well tolerated but may cause stomach discomfort in some people. ResearchGate+4PMC+4ScienceDirect+43. Acetyl-L-carnitineAcetyl-L-carnitine helps move fatty acids into mitochondria and supports energy production in nerves. Research in diabetic neuropathy suggests possible improvements in nerve conduction and sensory symptoms at doses around 1500–3000 mg per day in adults, but evidence is still limited. It may help nerve repair by supporting mitochondrial health and reducing oxidative stress. Side effects can include nausea and diarrhoea at high doses. Health+3PMC+3Exploration Publishing+34. B-complex vitamins (B1, B6, B9, B12)B-vitamins support nerve metabolism and myelin formation. In people who are deficient, replacing these vitamins can improve nerve function and reduce neuropathic symptoms. B12 deficiency in particular can worsen neuropathy, so levels are often checked in people with nerve disease. Doses vary depending on the vitamin and lab results, and high doses of B6 over long periods can themselves damage nerves, so medical supervision is needed. MDPI+2MedRxiv+25. Vitamin DVitamin D plays a role in immune regulation, muscle function, and bone strength. Low vitamin D has been linked with worse pain and poorer function in some chronic pain and neuropathy studies. Correcting deficiency with doses chosen by a doctor may help general health and possibly pain. However, too much vitamin D can cause high calcium levels, so blood monitoring is important. Frontiers+2MedRxiv+26. Omega-3 fatty acids (fish oil)Omega-3 fats from fish oil have anti-inflammatory and neuroprotective actions. Experimental studies suggest they may support nerve repair and reduce inflammation in chronic nerve injury. They are often taken as capsules or through eating oily fish several times per week. High doses can thin the blood slightly and may not be suitable for people on anticoagulants. Evidence specific to CMT is lacking, so they should be viewed as general health support rather than disease-specific therapy. ScienceDirect+2PMC+27. N-acetylcysteine (NAC)NAC is an antioxidant and a source of glutathione, the body’s main internal antioxidant. Some studies in neuropathy and chronic pain suggest that NAC, often at doses around 600–1800 mg per day in adults, may reduce pain when combined with medicines. Side effects can include stomach upset and, rarely, allergic reactions. It should be used only under medical guidance. ScienceDirect+2MedRxiv+28. MagnesiumMagnesium is involved in nerve and muscle function. In some pain conditions, magnesium supplements may help reduce muscle cramps and central sensitization. However, strong data in CMT are lacking. Too much magnesium, especially in people with kidney disease, can be dangerous, so doses should be modest and agreed with a doctor. MDPI+2ScienceDirect+29. Curcumin (turmeric extract)Curcumin has anti-inflammatory and antioxidant properties, and experimental work suggests it may protect nerves from oxidative damage. Bioavailability is a major issue, so special formulations are often used in studies. Evidence in human peripheral neuropathy is still early, so curcumin should be considered a possible supportive supplement rather than a proven treatment. ScienceDirect+2PMC+210. Combined antioxidant formulasSome products combine ALA, CoQ10, B-vitamins, and other antioxidants. Small studies in neuropathy suggest that combinations can improve symptoms in some patients, but study sizes are small and results are mixed. Because combinations increase the risk of interactions and high total doses, they should only be used after reviewing all ingredients with a healthcare professional. ScienceDirect+2MedRxiv+2Regenerative, immune-boosting and stem-cell-related drugsAt the moment, no regenerative drug, immune-booster, or stem-cell drug is approved by the FDA for CMT2X or any CMT subtype. Research is ongoing, and some approaches are promising, but they are only available in clinical trials:Gene-targeted therapies – Experimental work is exploring gene delivery of healthy GJB1 into nerves to correct the underlying defect. Animal models of X-linked CMT have shown that delivering the correct gene can improve nerve structure, but this is still early-stage and not ready for routine human treatment. practicalneurology.com+2MDPI+2Neuroprotective agents – Some experimental drugs aim to protect nerve cells by supporting chaperone proteins, mitochondrial function, or axonal transport. For example, new small molecules are being studied in CMT1A and may later be tested in other subtypes, but no standard regimen exists yet. MDPI+2American Chemical Society Publications+2Stem cell and cell-based therapies – Research groups are studying how stem cells or engineered cells might support nerve repair, but these are confined to laboratories and very early clinical research. Doses, routes, and long-term safety are unknown, so commercial “stem-cell clinics” advertising cures should be viewed with great caution. MDPI+2Frontiers+2Because of this, it would not be safe or honest to list specific “regenerative drug” names with fixed doses for CMT2X. If you are interested in research, your neurologist can help you check legitimate clinical trial registries instead.Surgical options1. Foot deformity corrective surgery (for pes cavus and claw toes)In some people with CMT2X, the arches of the feet become very high and stiff, and the toes curl, causing pain, pressure sores, and difficulty finding shoes. Corrective foot surgery can include soft-tissue releases and bone cuts (osteotomies) to rebalance the foot. The goal is a plantigrade (flatter, more stable) foot that fits in normal shoes and reduces pain and falls. Surgery is usually considered when braces and orthoses are not enough. Pod NMD+2The Foundation for Peripheral Neuropathy+22. Tendon transfer proceduresTendon transfers move a stronger muscle’s tendon to take over the job of a weak muscle—for example, transferring a functioning tendon to help lift the foot in people with foot drop. In CMT, tendon transfers can improve active movement and reduce the need for braces. They are carefully planned using gait analysis and nerve studies, and are usually combined with other foot procedures. Lippincott Journals+2Pod NMD+23. Osteotomies and joint fusionWhen deformities are severe and long-standing, surgeons may cut and realign bones (osteotomies) or fuse certain joints to stabilize the foot or ankle. The purpose is long-lasting stability and pain relief, even if some joint movement is sacrificed. This may be important in adult CMT patients with rigid deformities and arthritis. Pod NMD+2The Foundation for Peripheral Neuropathy+24. Spine surgery for scoliosis (in selected cases)Some people with CMT develop scoliosis (sideways curvature of the spine). If the curve is large, painful, or affects breathing, spine surgery may be considered. The goal is to prevent progression, reduce pain, and protect lung function. Most people with CMT2X do not need this, but it is part of the broader surgical toolbox. MDPI+2Lippincott Journals+25. Nerve decompression for entrapment neuropathiesIf someone with CMT2X also develops a compressed nerve (for example carpal tunnel syndrome), decompression surgery may be offered. This does not treat the genetic neuropathy but can relieve extra pressure on already fragile nerves, improving pain or function in that area. MDPI+2ScienceDirect+2Prevention and lifestyle measuresCMT2X itself cannot be prevented, but many complications can be reduced:Keep a healthy weight to lessen stress on weak feet and legs and improve walking. NCBI+2Taylor & Francis Online+2Stay physically active within safe limits, using a physiotherapist-designed program. PubMed+2MDPI+2Avoid medicines that are known to be toxic to peripheral nerves whenever possible, and ask your neurologist before starting any new drug. NCBI+2MDPI+2Protect your feet with good footwear and daily skin checks to prevent ulcers and infections. The Foundation for Peripheral Neuropathy+2Pod NMD+2Use braces or walking aids early when recommended, rather than waiting for repeated falls. MDPI+2PMC+2Keep bones strong with enough vitamin D and weight-bearing activity, as agreed with your doctor. Frontiers+2MedRxiv+2Manage other health conditions such as diabetes or thyroid problems that can worsen neuropathy. MDPI+2ScienceDirect+2Have regular check-ups with a neurologist, physiotherapist, and foot-care specialist to adjust treatment as you grow or age. NCBI+2Charcot-Marie-Tooth Association+2Consider genetic counseling when planning a family, to understand transmission risks and options. NCBI+2BCBSM+2Avoid smoking and heavy alcohol intake, which can further damage nerves and muscles. MDPI+2ScienceDirect+2When to see doctorsYou should see or contact your doctor (and tell your family) if you notice:New or rapidly worsening weakness, balance problems, or falls.New severe pain, especially at night, or pain that suddenly changes.Ulcers, colour changes, or infections on your feet or legs.New problems with bladder, bowel, swallowing, or breathing.Sudden changes in mood, such as feeling very low, hopeless, or having thoughts of harming yourself or others.In these situations, seeing a neurologist or going to urgent care early can prevent permanent problems. Guidelines for CMT recommend at least yearly review by a neurologist, plus more frequent visits when symptoms change. NCBI+2MDPI+2What to eat and what to avoidThere is no special “CMT2X diet,” but good nutrition supports nerve, muscle, and bone health:Eat plenty of colourful fruits and vegetables to supply antioxidants and vitamins that help protect cells from damage. ScienceDirect+2Frontiers+2Choose lean protein sources (fish, poultry, beans, lentils) to support muscle repair and strength. PMC+2ScienceDirect+2Include healthy fats such as olive oil, nuts, seeds, and oily fish for omega-3 fatty acids and anti-inflammatory effects. ScienceDirect+2PMC+2Prefer whole grains over refined grains to keep blood sugar stable and reduce the risk of diabetes, which can worsen neuropathy. PMC+2MDPI+2Drink enough water to stay well hydrated, which helps general health and may reduce cramps. ScienceDirect+2MedRxiv+2Limit sugary drinks and sweets, which can lead to weight gain and poor blood sugar control. PMC+2MDPI+2Avoid excessive fast food and deep-fried foods, which are high in saturated and trans fats and can harm heart and nerve health. ScienceDirect+2article.imrpress.com+2Limit alcohol, as heavy drinking can damage nerves and interact with medicines used for neuropathic pain. MDPI+2Brieflands+2Avoid extreme crash diets, which can cause muscle loss and fatigue in people already struggling with weakness. Taylor & Francis Online+2Archives PMR+2Talk with your doctor before taking any supplement, especially if you already use medicines for pain, mood, seizures, or heart disease. MedRxiv+2ScienceDirect+2Frequently asked questions (FAQs)1. Is Charcot-Marie-Tooth neuropathy type 2X curable?No. At present, CMT2X is a lifelong genetic condition without a cure. Treatments aim to manage symptoms, protect function, and prevent complications. Research into gene therapy and neuroprotective drugs is active, but these approaches are still experimental and not part of routine care yet. NCBI+2MDPI+22. Can exercise make my CMT2X worse?Well-planned, moderate exercise guided by a physiotherapist is usually safe and helpful. Studies show that strength, endurance, and balance training can improve function without worsening nerve damage when over-fatigue is avoided. Over-exercising to the point of severe, lasting muscle soreness is not advised. PubMed+2PMC+23. Why are braces and orthoses important?Braces such as AFOs help support weak ankles and feet, reduce tripping, and allow you to walk longer with less effort. Evidence in CMT shows that orthoses improve foot function and pain when they are properly fitted and used alongside therapy. The Foundation for Peripheral Neuropathy+2Pod NMD+24. Will I eventually need a wheelchair?Some people with CMT2X may use a wheelchair for longer distances, especially as they get older, but many remain able to walk with or without aids. The course is very variable. Regular therapy, good foot care, and healthy lifestyle choices can help maintain mobility as long as possible. NCBI+2MDPI+25. Can medicines stop the nerve damage?No medicine has yet been proven to slow or stop the underlying nerve damage in CMT2X. Drugs mainly relieve pain or cramps and support mood and sleep. That is why non-drug measures and future research are so important. ScienceDirect+2MDPI+26. Are supplements like alpha-lipoic acid or CoQ10 mandatory?They are not mandatory. Some studies in other neuropathies suggest possible benefit, but evidence for CMT2X is limited. They should be viewed as optional, supportive tools—not as cures—and should only be started after discussing with your doctor to avoid interactions and unnecessary cost. Health+3PMC+3PMC+37. Is CMT2X only a problem for the nerves in the legs?CMT2X mainly affects peripheral nerves, especially in the legs and feet first, but it can also involve the hands and, in some people, the central nervous system, causing subtle brain or spinal cord signs. This is why careful neurological follow-up is recommended. NCBI+2Frontiers+28. Can diet alone fix my neuropathy?No diet can fix the genetic cause of CMT2X. However, healthy eating helps keep weight, blood sugar, heart health, and bone strength under control, which indirectly protects nerve function and mobility. Diet works best when combined with therapy and medical care. Taylor & Francis Online+2article.imrpress.com+29. Is it safe to join sports at school?Many people with CMT can safely join adapted sports or physical education with some modifications, such as using braces, avoiding high-impact jumps, and taking rest breaks. Sports like swimming or cycling are often well tolerated. A physiotherapist and school staff can help choose safe activities. ScienceDirect+2MDPI+210. Should my family members be tested?Because CMT2X is inherited, other family members may carry the gene, even if they have mild or no symptoms. Genetic counseling helps your family decide who should be tested and what the results might mean for them. NCBI+2BCBSM+211. Will pregnancy make CMT2X worse?Some women with CMT report temporary worsening of symptoms during pregnancy due to weight gain, fluid shifts, and hormonal changes, but others notice little change. Careful obstetric and neurologic follow-up and planning for delivery are recommended. NCBI+2MDPI+212. Can CMT2X affect my thinking or learning?Most people with CMT2X have normal intelligence. A small number may show subtle brain involvement such as transient white matter changes or coordination issues, but significant learning disability is not typical. Any new cognitive changes should be evaluated to look for other causes. NCBI+2Frontiers+213. Are experimental treatments available for me now?Some clinical trials for CMT are running in specialised centres, mostly for CMT1A and other subtypes. Gene-based or chaperone-based treatments for GJB1-related disease are still at an early research stage. Your neurologist can help you search reputable clinical trial registries to see if there is anything relevant and safe. MDPI+2practicalneurology.com+214. Why do doctors focus so much on feet and shoes?In CMT2X, foot deformities, poor sensation, and weakness combine to make the feet especially vulnerable to pain, sores, and falls. Footwear, orthoses, and regular checks are simple but powerful tools to keep you walking safely and comfortably. The Foundation for Peripheral Neuropathy+2Pod NMD+215. What is the most important thing I can do right now?The most important steps are: stay linked with a neurologist who knows CMT, follow a regular physiotherapy and stretching program, protect your feet, keep a healthy lifestyle, and talk openly about pain or mood changes. These simple, steady actions make a big difference over many years, especially when started early in life. MDPI+3NCBI+3PMC+3Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.The article is written by Team RxHarun and reviewed by the Rx Editorial Board MembersLast Updated: December 23, 2025.PDF Documents For This Disease ConditionRare Diseases and Medical Genetics.[rxharun.com] i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com] the-UK-rare-diseases-framework.[rxharun.com] National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com] History of rare diseases and their genetic.[rxharun.com] health-care-and-rare-disorders.[rxharun.com] Rare Disease Registries.[rxharun.com] autoimmune-Rare-Genetic-Diseases.[rxharun.com] Rare Genetic Diseases.[rxharun.com] rare-disease-day.[rxharun.com] Rare_Disease_Drugs_e.[rxharun.com] fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com] rare-and-inherited-disease-eligibility-criteria.[rxharun.com] FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]FDA-rare-disease-lists.[rxharun.com] 30212783fnl_Rare Disease.[rxharun.com] FDA-rare-disease-list.[rxharun.com] List of rare disease.[rxharun.com] Genome Res.-2025-Steyaert-755-68.[rxharun.com] uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com] PIIS2949774424010355.[rxharun.com] hidden-costs-2016.[rxharun.com] B156_CONF2-en.[rxharun.com] IRDiRC_State-of-Play-2018_Final.[rxharun.com] IRDR_2022Vol11No3_pp96_160.[rxharun.com] from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com] Rare disease fda.[rxharun.com] England-Rare-Diseases-Action-Plan-2022.[rxharun.com] SCRDAC 2024 Report.[rxharun.com] CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com] Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com] rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com] ENG_White paper_A4_Digital_FINAL.[rxharun.com] UK_Strategy_for_Rare_Diseases.[rxharun.com] MalaysiaRareDiseaseList.[rxharun.com] EURORDISCARE_FULLBOOKr.[rxharun.com] EMHJ_1999_5_6_1104_1113.[rxharun.com] national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com] be-counted-052722-WEB.[rxharun.com] RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com] genomic-analysis-of-rare-disease-brochure.[rxharun.com] List-of-rare-diseases.[rxharun.com] RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com] rdnumbers.[rxharun.com] .Rare disease atoz .[rxharun.com] EmanPublisher_12_5830biosciences-.[rxharun.com]Referenceshttps://www.ncbi.nlm.nih.gov/books/NBK208609/https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/https://rarediseases.org/rare-diseases/https://rarediseases.info.nih.gov/diseaseshttps://en.wikipedia.org/w/index.php?title=Category:Rare_diseaseshttps://en.wikipedia.org/wiki/List_of_genetic_disordershttps://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disordershttps://medlineplus.gov/genetics/condition/https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.fda.gov/patients/rare-diseases-fdahttps://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-programhttps://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltexthttps://www.ncbi.nlm.nih.gov/mesh?https://www.rarediseasesinternational.org/working-with-the-who/https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7https://www.rarediseasesnetwork.org/https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-diseasehttps://www.raregenomics.org/rare-disease-listhttps://www.astrazeneca.com/our-therapy-areas/rare-disease.htmlhttps://bioresource.nihr.ac.uk/rarehttps://www.roche.com/solutions/focus-areas/neuroscience/rare-diseaseshttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomicshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026https://wikicure.fandom.com/wiki/Rare_Diseaseshttps://www.wikidoc.org/index.php/List_of_genetic_disordershttps://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/https://www.orpha.net/en/disease/listhttps://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspxhttps://ojrd.biomedcentral.com/https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_enhttps://bioportal.bioontology.org/ontologies/ORDOhttps://www.orpha.net/en/disease/listhttps://www.fda.gov/industry/medical-products-rare-diseases-and-conditionshttps://www.gao.gov/products/gao-25-106774https://www.gene.com/partners/what-we-are-looking-for/rare-diseaseshttps://www.genome.gov/For-Patients-and-Families/Genetic-Disordershttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://my.clevelandclinic.org/health/diseases/21751-genetic-disordershttps://globalgenes.org/rare-disease-facts/https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nordhttps://byjus.com/biology/genetic-disorders/https://www.cdc.gov/genomics-and-health/about/genetic-disorders.htmlhttps://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/https://www.thegenehome.com/basics-of-genetics/disease-exampleshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://www.pfizerclinicaltrials.com/our-research/rare-diseaseshttps://clinicaltrials.gov/ct2/results?recrshttps://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdfhttps://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239https://www.nibib.nih.gov/https://www.nei.nih.gov/https://oxfordtreatment.com/https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/https://www.nccih.nih.gov/healthhttps://catalog.ninds.nih.gov/https://www.aarda.org/diseaselist/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheetshttps://www.nibib.nih.gov/https://www.nia.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.nimh.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.niehs.nih.gov/https://www.nimhd.nih.gov/https://www.nhlbi.nih.gov/health-topicshttps://obssr.od.nih.gov/.https://www.nichd.nih.gov/health/topicshttps://rarediseases.info.nih.gov/diseaseshttps://beta.rarediseases.info.nih.gov/diseaseshttps://orwh.od.nih.gov/SaveSavedRemoved 0 PreviousCharcot-Marie-Tooth Disease Caused by Mutation in SPG11 NextCharcot-Marie-Tooth Disease Axonal Type 2Z (CMT2Z) Related ArticlesAdded to wishlistRemoved from wishlist 0 Neuropathy Hereditary Motor and Sensory Type 1CAdded to wishlistRemoved from wishlist 0 Charcot-Marie-Tooth Neuropathy Dominant Intermediate BAdded to wishlistRemoved from wishlist 0 Hereditary Adult-Onset Painful Axonal PolyneuropathyAdded to wishlistRemoved from wishlist 0 Hereditary Adult-Onset Painful Axonal Polyneuropathy